Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery

BACKGROUND: Conventional treatment for locally advanced rectal cancer usually combines neoadjuvant radiochemotherapy and surgery. Until recently, there have been limited predictive factors (clinical or biological) for rectal tumor response to conventional treatment. KRAS, BRAF and PIK3CA mutations a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Derbel, Olfa, Wang, Qing, Desseigne, Françoise, Rivoire, Michel, Meeus, Pierre, Peyrat, Patrice, Stella, Mattia, Martel-Lafay, Isabelle, Lemaistre, Anne-Isabelle, de La Fouchardière, Christelle
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640970/
https://ncbi.nlm.nih.gov/pubmed/23617638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-200
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak